Novel SCN3A variants associated with focal epilepsy in children

Carlos G. Vanoye, Christina A. Gurnett, Katherine D. Holland, Alfred L. George, Jennifer A. Kearney*

*Corresponding author for this work

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Voltage-gated sodium (NaV) channels are essential for initiating and propagating action potentials in the brain. More than 800 mutations in genes encoding neuronal NaV channels including SCN1A and SCN2A have been associated with human epilepsy. Only one epilepsy-associated mutation has been identified in SCN3A encoding the NaV1.3 neuronal sodium channel. We performed a genetic screen of pediatric patients with focal epilepsy of unknown cause and identified four novel SCN3A missense variants: R357Q, D766N, E1111K and M1323V. We determined the functional consequences of these variants along with the previously reported K354Q mutation using heterologously expressed human NaV1.3. Functional defects were heterogeneous among the variants. The most severely affected was R357Q, which had a significantly smaller current density and slower activation than the wild-type (WT) channel as well as depolarized voltage dependences of activation and inactivation. Also notable was E1111K, which evoked a significantly greater level of persistent sodium current than WT channels. Interestingly, a common feature shared by all variant channels was increased current activation in response to depolarizing voltage ramps revealing a functional property consistent with conferring neuronal hyper-excitability. Discovery of a common biophysical defect among variants identified in unrelated pediatric epilepsy patients suggests that SCN3A may contribute to neuronal hyperexcitability and epilepsy.

Original languageEnglish (US)
Pages (from-to)313-322
Number of pages10
JournalNeurobiology of Disease
Volume62
DOIs
StatePublished - Jan 1 2014

Fingerprint

Partial Epilepsy
Epilepsy
Mutation
Pediatrics
Voltage-Gated Sodium Channels
Architectural Accessibility
Sodium Channels
Action Potentials
Sodium
Brain
Genes

Keywords

  • Epilepsy
  • Persistent current
  • Ramp currents
  • SCN3A
  • Sodium channel

ASJC Scopus subject areas

  • Neurology

Cite this

@article{788bf43435d641ca9d7be49ebb63e80e,
title = "Novel SCN3A variants associated with focal epilepsy in children",
abstract = "Voltage-gated sodium (NaV) channels are essential for initiating and propagating action potentials in the brain. More than 800 mutations in genes encoding neuronal NaV channels including SCN1A and SCN2A have been associated with human epilepsy. Only one epilepsy-associated mutation has been identified in SCN3A encoding the NaV1.3 neuronal sodium channel. We performed a genetic screen of pediatric patients with focal epilepsy of unknown cause and identified four novel SCN3A missense variants: R357Q, D766N, E1111K and M1323V. We determined the functional consequences of these variants along with the previously reported K354Q mutation using heterologously expressed human NaV1.3. Functional defects were heterogeneous among the variants. The most severely affected was R357Q, which had a significantly smaller current density and slower activation than the wild-type (WT) channel as well as depolarized voltage dependences of activation and inactivation. Also notable was E1111K, which evoked a significantly greater level of persistent sodium current than WT channels. Interestingly, a common feature shared by all variant channels was increased current activation in response to depolarizing voltage ramps revealing a functional property consistent with conferring neuronal hyper-excitability. Discovery of a common biophysical defect among variants identified in unrelated pediatric epilepsy patients suggests that SCN3A may contribute to neuronal hyperexcitability and epilepsy.",
keywords = "Epilepsy, Persistent current, Ramp currents, SCN3A, Sodium channel",
author = "Vanoye, {Carlos G.} and Gurnett, {Christina A.} and Holland, {Katherine D.} and George, {Alfred L.} and Kearney, {Jennifer A.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.nbd.2013.10.015",
language = "English (US)",
volume = "62",
pages = "313--322",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

Novel SCN3A variants associated with focal epilepsy in children. / Vanoye, Carlos G.; Gurnett, Christina A.; Holland, Katherine D.; George, Alfred L.; Kearney, Jennifer A.

In: Neurobiology of Disease, Vol. 62, 01.01.2014, p. 313-322.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Novel SCN3A variants associated with focal epilepsy in children

AU - Vanoye, Carlos G.

AU - Gurnett, Christina A.

AU - Holland, Katherine D.

AU - George, Alfred L.

AU - Kearney, Jennifer A.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Voltage-gated sodium (NaV) channels are essential for initiating and propagating action potentials in the brain. More than 800 mutations in genes encoding neuronal NaV channels including SCN1A and SCN2A have been associated with human epilepsy. Only one epilepsy-associated mutation has been identified in SCN3A encoding the NaV1.3 neuronal sodium channel. We performed a genetic screen of pediatric patients with focal epilepsy of unknown cause and identified four novel SCN3A missense variants: R357Q, D766N, E1111K and M1323V. We determined the functional consequences of these variants along with the previously reported K354Q mutation using heterologously expressed human NaV1.3. Functional defects were heterogeneous among the variants. The most severely affected was R357Q, which had a significantly smaller current density and slower activation than the wild-type (WT) channel as well as depolarized voltage dependences of activation and inactivation. Also notable was E1111K, which evoked a significantly greater level of persistent sodium current than WT channels. Interestingly, a common feature shared by all variant channels was increased current activation in response to depolarizing voltage ramps revealing a functional property consistent with conferring neuronal hyper-excitability. Discovery of a common biophysical defect among variants identified in unrelated pediatric epilepsy patients suggests that SCN3A may contribute to neuronal hyperexcitability and epilepsy.

AB - Voltage-gated sodium (NaV) channels are essential for initiating and propagating action potentials in the brain. More than 800 mutations in genes encoding neuronal NaV channels including SCN1A and SCN2A have been associated with human epilepsy. Only one epilepsy-associated mutation has been identified in SCN3A encoding the NaV1.3 neuronal sodium channel. We performed a genetic screen of pediatric patients with focal epilepsy of unknown cause and identified four novel SCN3A missense variants: R357Q, D766N, E1111K and M1323V. We determined the functional consequences of these variants along with the previously reported K354Q mutation using heterologously expressed human NaV1.3. Functional defects were heterogeneous among the variants. The most severely affected was R357Q, which had a significantly smaller current density and slower activation than the wild-type (WT) channel as well as depolarized voltage dependences of activation and inactivation. Also notable was E1111K, which evoked a significantly greater level of persistent sodium current than WT channels. Interestingly, a common feature shared by all variant channels was increased current activation in response to depolarizing voltage ramps revealing a functional property consistent with conferring neuronal hyper-excitability. Discovery of a common biophysical defect among variants identified in unrelated pediatric epilepsy patients suggests that SCN3A may contribute to neuronal hyperexcitability and epilepsy.

KW - Epilepsy

KW - Persistent current

KW - Ramp currents

KW - SCN3A

KW - Sodium channel

UR - http://www.scopus.com/inward/record.url?scp=84887358909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887358909&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2013.10.015

DO - 10.1016/j.nbd.2013.10.015

M3 - Article

C2 - 24157691

AN - SCOPUS:84887358909

VL - 62

SP - 313

EP - 322

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -